(1R,2S,6R,7S)-4-{[(1R,2R)-2-{[4-(1,2-Benzothiazol-3-yl)-1-piperazinyl]methyl}cyclohexyl]methyl}-4-azatricyclo[5.2.1.0~2,6~]decane-3,5-dione(CAS: 367514-87-2)
![(1R,2S,6R,7S)-4-{[(1R,2R)-2-{[4-(1,2-Benzothiazol-3-yl)-1-piperazinyl]methyl}cyclohexyl]methyl}-4-azatricyclo[5.2.1.0~2,6~]decane-3,5-dione (1R,2S,6R,7S)-4-{[(1R,2R)-2-{[4-(1,2-Benzothiazol-3-yl)-1-piperazinyl]methyl}cyclohexyl]methyl}-4-azatricyclo[5.2.1.0~2,6~]decane-3,5-dione](https://static.chemtradehub.com/structs/367/367514-87-2-b7ba.webp)
CAS Number
Related Products
Cycloheptanecarboxamide
CAS Number: 1459-39-8
3-Chloro-1H-1,2,4-triazole
CAS Number: 6818-99-1
2-Methoxy-3-nitro-4-pyridinamine
CAS Number: 33623-16-4
Stanozolol
CAS Number: 10418-03-8
Other Suppliers for (1R,2S,6R,7S)-4-{[(1R,2R)-2-{[4-(1,2-Benzothiazol-3-yl)-1-piperazinyl]methyl}cyclohexyl]methyl}-4-azatricyclo[5.2.1.0~2,6~]decane-3,5-dione
Basic Information
Molecular Formula
C28H36N4O2S
Molecular Weight
492.69 g/mol
Physical State
Powder
Physical Properties
Melting Point
147-150°C
Chemical Identifiers
SMILES
O=C1[C@H]2[C@@H]3CC[C@@H](C3)[C@H]2C(=O)N1C[C@@H]4CCCC[C@H]4CN5CCN(CC5)c6nsc7ccccc67
InChIKey
PQXKDMSYBGKCJA-CVTJIBDQSA-N
Database References
MDL Number
MFCD14635357
FAQ
The compound (1R,2S,6R,7S)-4-{[(1R,2R)-2-{[4-(1,2-Benzothiazol-3-yl)-1-piperazinyl]methyl}cyclohexyl]methyl}-4-azatricyclo[5.2.1.0~2,6~]decane-3,5-dione (CAS: 367514-87-2) is subject to various regulatory guidelines, including REACH regulations for its safety and environmental impact. It may also require GHS classification based on its properties, such as potential toxicity or flammability. Additionally, FDA/EPA may have specific requirements for its use in pharmaceuticals or industrial applications, respectively.
In synthesis, there are several alternatives to (1R,2S,6R,7S)-4-{[(1R,2R)-2-{[4-(1,2-Benzothiazol-3-yl)-1-piperazinyl]methyl}cyclohexyl]methyl}-4-azatricyclo[5.2.1.0~2,6~]decane-3,5-dione (CAS: 367514-87-2). These include the use of related isomers and analogs, such as (1R,2S,6R,7S)-4-{[(1R,2R)-2-{[4-(1,2-Benzothiazol-3-yl)-1-piperazinyl]methyl}cyclohexyl]methyl}-4-azatricyclo[5.2.1.0~2,6~]decane-3-dione, as well as alternative reagents like other azatricyclic compounds with similar functional groups.
The market for (1R,2S,6R,7S)-4-{[(1R,2R)-2-{[4-(1,2-Benzothiazol-3-yl)-1-piperazinyl]methyl}cyclohexyl]methyl}-4-azatricyclo[5.2.1.0~2,6~]decane-3,5-dione (CAS: 367514-87-2) is currently focused on its potential applications in pharmaceuticals and research. There is increasing interest in the development of novel compounds with similar structural features for use in drug discovery and development. Research trends indicate a growing focus on the synthesis and evaluation of isomers and analogs for improved efficacy and safety.
Waste containing (1R,2S,6R,7S)-4-{[(1R,2R)-2-{[4-(1,2-Benzothiazol-3-yl)-1-piperazinyl]methyl}cyclohexyl]methyl}-4-azatricyclo[5.2.1.0~2,6~]decane-3,5-dione (CAS: 367514-87-2) should be collected in appropriate containers and stored in a secure, well-ventilated area. For disposal, it is recommended to use professional waste disposal services that specialize in hazardous chemicals. Environmental protection precautions should include ensuring proper containment to prevent accidental spills or leaks. Additionally, incineration may be a suitable method for disposing of the waste, provided it is conducted in an environmentally compliant manner.
Safety Notice
Please verify product specifications and safety data before use. Contact the supplier for detailed safety information.
Always follow proper handling procedures
Contact Information
order@canspecsci.com
Mobile
15021221957
Telephone
021-59553580
Fax
021-59553580-8012
Visit Website
https://www.canspec.cn
![[(1alpha,6beta,14alpha,16beta)-20-Ethyl-7,8-dihydroxy-1,6,14,16-tetramethoxyaconitan-4-yl]methyl 2-[(3S)-3-methyl-2,5-dioxo-1-pyrrolidinyl]benzoate 2-hydroxy-1,2,3-propanetricarboxylate (1:1)](https://static.chemtradehub.com/structs/351/351344-10-0-4e0e.webp)
![4-[(E)-2-(4-Carbamimidoylphenyl)vinyl]-3-hydroxybenzenecarboximidamide methanesulfonate (1:2)](https://static.chemtradehub.com/structs/223/223769-64-0-1600.webp)

![(6R,7R)-3-(acetyloxymethyl)-7-[[(2Z)-2-(furan-2-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid](https://static.chemtradehub.com/structs/396/39685-31-9-f1d8.webp)





![(1R,2S,6R,7S)-4-{[(1R,2R)-2-{[4-(1,2-Benzothiazol-3-yl)-1-piperazinyl]methyl}cyclohexyl]methyl}-4-azatricyclo[5.2.1.0~2,6~]decane-3,5-dione — MedChemExpress LLC](https://static.chemtradehub.com/suppliers/67ced0fb2b2de6e8e95a67fd/67ced0fb2b2de6e8e95a67fd-logo.webp)
![(1R,2S,6R,7S)-4-{[(1R,2R)-2-{[4-(1,2-Benzothiazol-3-yl)-1-piperazinyl]methyl}cyclohexyl]methyl}-4-azatricyclo[5.2.1.0~2,6~]decane-3,5-dione — Shanghai Jixiang Biotechnology Co., Ltd.](https://static.chemtradehub.com/suppliers/67ce6f4d2b2de6e8e95a45bf/67ce6f4d2b2de6e8e95a45bf-logo.webp)